Somers, NY, United States of America

Shirlynn Chen

This inventor holds 4 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: Boehringer Ingelheim International Gmbh, Boehringer Ingelheim Pharmaceuticals, Inc.. Active years: 2003-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shirlynn Chen. Retrieved from https://idiyas.com/inventor/shirlynn-chen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 4 

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.8

ph-index = 3

Forward Citations = 39(Granted Patents)


Company Filing History:


Years Active: 2003-2013

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations of Inventor Shirlynn Chen

Introduction

Shirlynn Chen is a notable inventor based in Somers, NY (US). She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of Hepatitis C. With a total of four patents to her name, her work has had a substantial impact on medical science.

Latest Patents

One of her latest patents is titled "Solid state forms of a potent HCV inhibitor." This invention relates to novel sodium salt forms of a specific compound and methods for their preparation, as well as pharmaceutical compositions for treating Hepatitis C Viral (HCV) infection. Another significant patent is "Pharmaceutical compositions for hepatitis C viral protease inhibitors." This patent discloses pharmaceutical compositions that include hepatitis C viral protease inhibitors and methods for using these compositions to inhibit the replication of the hepatitis C virus. These compositions are lipid-based systems that comprise the inhibitor along with various pharmaceutically acceptable ingredients.

Career Highlights

Shirlynn Chen has worked with prominent companies in the pharmaceutical industry, including Boehringer Ingelheim International GmbH and Boehringer Ingelheim Pharmaceuticals, Inc. Her experience in these organizations has allowed her to develop innovative solutions for complex medical challenges.

Collaborations

Some of her notable coworkers include Xiaohui Mei and Zeren Wang. Their collaborative efforts have contributed to the advancement of research and development in the field of Hepatitis C treatment.

Conclusion

Shirlynn Chen's contributions to pharmaceutical innovations, particularly in the treatment of Hepatitis C, highlight her role as a leading inventor in the industry. Her patents and collaborations reflect her commitment to improving healthcare outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…